Showing 121 - 140 results of 295 for search '"hepatitis B virus"', query time: 0.07s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128

    Treatment of end-stages of liver disease in outcome of persistent hepatitis C virus infection at deficiency of donor organs by Ye. N. German, M. V. Mayevskaya, O. I. Andreytseva, V. T. Ivashkin, A. V. Chzhao, A. G. Serova, G. V. Mikhaylovskaya, I. Yu. Pirogova

    Published 2011-03-01
    “…To study the role of serological markers of hepatitis B virus infection: antibodies to hepatitis B virus cor-antigen (anti-HВcor IgG) in progressing liver damage at patients with persistent hepatitis C virus infection.Material and methods. …”
    Get full text
    Article
  9. 129

    Family Practitioners and Sexually Transmitted Diseases by Marc Steben

    Published 1991-01-01
    “…Prostitutes, street youth and sexually abused individuals should be considered at high risk for hepatitis B virus infection. Counselling about hepatitis B virus infection involves risk evaluation, patient education, evaluation of immune status to hepatitis B virus and discussions about vaccine needs and availability.…”
    Get full text
    Article
  10. 130

    STUDI PERBANDINGAN PEMAKAIAN PRIMER HBS1 DAN HBS2 DENGAN PRIMER P7 DAN P8 DALAM DETEKSI DNA VIRUS HEPATITIS B PADA PENDONOR DARAH by Supiana Dian Nurtjahyani, Mohammad Amin, Retno Handajan

    Published 2020-11-01
    “…Examination of the hepatitis B virus as a disease of hepatitis serologically has been carried out a lot, but this serological examination can experience problems if there is a low window period, so even though a negative test result is still possible in a patient's body infected with the hepatitis B virus, a fast and accurate examination is needed. …”
    Get full text
    Article
  11. 131

    Low viral persistence of an immunological model by Suqi Ma

    Published 2012-09-01
    “…Hepatitis B virus can persist at very low levels in the body in the face of host immunity, and reactive during immunosuppression and sustain the immunological memory to lead to the possible state of 'infection immunity'. …”
    Get full text
    Article
  12. 132

    Epidemiology of Hepatitis B in Canada by Jun Zhang, Shimian Zou, Antonio Giulivi

    Published 2001-01-01
    “…OBJECTIVE: To provide a current and comprehensive review of the epidemiology of hepatitis B virus (HBV) in Canada.…”
    Get full text
    Article
  13. 133

    The Investigation of HBV Pre-S/S Gene Mutations in Occult HBV Infected Blood Donors with anti-HBs Positive by Yan Guo, Yu Lan, Yuanyuan Jing, Bin Cai, Hanshi Gong, Yixin Zhang, Yong Duan

    Published 2022-01-01
    “…The coexistence of hepatitis B virus (HBV) and hepatitis B surface antibodies (anti-HBs) in occult hepatitis B virus infection (OBI) is a contradictory phenomenon, and the underlying mechanism is not fully understood. …”
    Get full text
    Article
  14. 134

    Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort by Antoanela Curici, Olivia Mioara Ilie, Dana Elena Mindru

    Published 2025-01-01
    “…Hepatitis B virus (HBV) infections remain a significant global health challenge, especially in low- and middle-income countries where access to healthcare services is often limited. …”
    Get full text
    Article
  15. 135

    Seroprevalence of Cytomegalovirus, Toxoplasma gondii, Syphilis, and Hepatitis B and C Virus Infections in a Regional Population Seropositive for HIV Infection by Daniel G Johns, M John Gill

    Published 1998-01-01
    “…OBJECTIVE: To determine the prevalence of exposure to cytomegalovirus (CMV), Toxoplasma gondii, syphilis, hepatitis B virus (HBV) and hepatitis C virus (HCV) in a large, well characterized, regional population presenting for human immunodeficency virus (HIV) care.…”
    Get full text
    Article
  16. 136

    Acute Coinfection with Hepatitis B and Hepatitis C Viruses by Brian M Yan, Samuel S Lee

    Published 2005-01-01
    “…Acute coinfection of hepatitis B virus (HBV) and hepatitis C virus (HCV) is rare. …”
    Get full text
    Article
  17. 137

    Hepatitis C pada Anak by Yusri Dianne Jurnalis, Yorva Sayoeti, Adria Russelly

    Published 2014-05-01
    “…Infeksi HCV akut dapat berakhir dengan sirosis dan karsinoma hepatoselular setelah dekade ketiga (sekitar 20%), karena progresivitas infeksi HCV lebih lambat dari infeksi hepatitis B virus. Pada umumnya infeksi HCV bersifat asimptomatik termasuk pada anak. …”
    Get full text
    Article
  18. 138

    Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis by Lu Cao, Li Li, Lixing Yang, Nan Zhou, Yu Zhang

    Published 2025-01-01
    “…After 48 weeks, the hepatitis B virus-deoxyribonucleic acid clearance rate in the tenofovir group were comparable to the entecavir group. …”
    Get full text
    Article
  19. 139

    Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta-Analysis of Observational Studies by Behailu Terefe Tesfaye, Temesgen Mulugeta Feyissa, Azmeraw Bekele Workneh, Esayas Kebede Gudina, Mengist Awoke Yizengaw

    Published 2021-01-01
    “…On the other hand, the overall hospital mortality rate in CLD patients is 25.0% [95% CI: 2.0, 47.0, I2 = 94.6, p<0.001] in Ethiopia. Conclusion. Hepatitis B virus, hepatitis C virus, and alcohol are the three most common contributors to CLD cases in Ethiopia. …”
    Get full text
    Article
  20. 140

    Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning by Shuxian Pan, Zibing Wang

    Published 2025-01-01
    “…BackgroundImmune checkpoint inhibitors have proven efficacy against hepatitis B-virus positive hepatocellular. However, Immunotherapy-related adverse reactions are still a major challenge faced by tumor immunotherapy, so it is urgent to establish new methods to effectively predict immunotherapy-related adverse reactions.ObjectiveMulti-machine learning model were constructed to screen the risk factors for irAEs in ICIs for the treatment of HBV-related hepatocellular and build a prediction model for the occurrence of clinical IRAEs.MethodsData from 274 hepatitis B virus positive tumor patients who received PD-1 or/and CTLA4 inhibitor treatment and had immune cell detection results were collected from Henan Cancer Hospital for retrospective analysis. …”
    Get full text
    Article